Feed GSK
GS

GSK GSK · NYSE

$51.05 -0.10% (-$0.05)

Market cap
£76.7B
Enterprise value
£91.8B
P/E
15.9x
Forward P/E
10.3x
PEG
0.1x
P/S
2.3x
P/FCF
11.0x
EV/EBITDA
8.4x
ROIC
13.9%
Bruto marža
72.7%
Neto marža
14.5%
Dividend yield
3.57%
Payout ratio
56.8%
Neto dolg/EBITDA
1.4x
Beta
0.28
Free float
96.9%

O podjetju

GSK plc is a global pharmaceutical company with a long history and a wide portfolio of medicinal products. The company specializes in researching, developing, and manufacturing drugs for various therapeutic areas, including infectious diseases, respiratory conditions, oncology, immunology, and others. GSK is known for its iconic products and vaccines that help fight diseases worldwide. The company collaborates with research institutions and partners around the world to innovate in the field of medicines and provide new and effective treatment solutions. GSK is also actively working on the development of new vaccines and drugs, including vaccines for COVID-19. GSK plc (GSK) shares may be an interesting choice for investors who follow the pharmaceutical industry and seek investment opportunities in a long-established company with innovative research and a wide portfolio of medicinal products.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Luke Victor Miels

Employees

66,841

Headquarters

London

Vrednotenje

Je današnja cena primerna?

  • Kaj govori v prid: Za 1 GBP letnega dobička plačate 15,9 GBP, malo za njen sektor.

Rast in ocene

Ali podjetje raste in kaj sledi?

  • Na kaj bodite pozorni: Dobiček na delnico je v zadnjih 3 letih padal za 8,8 % letno.
  • Na kaj bodite pozorni: Dobiček na delnico iz leta v leto močno niha.

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

  • Kaj govori v prid: Od vsakih 100 GBP prihodkov ostane 15 GBP čistega dobička.
  • Kaj govori v prid: Na vsakih 100 GBP vloženega kapitala zasluži 14 GBP letno.

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.